苏州奕赛生物科技有限公司代理商

3

手机商铺

qrcode
商家活跃:
产品热度:
  • NaN
  • 0
  • 0
  • 2
  • 2
代理商

苏州奕赛生物科技有限公司

入驻年限:3

  • 联系人:

    王经理

  • 所在地区:

    江苏 苏州市 姑苏区

  • 业务范围:

    试剂、抗体、细胞库 / 细胞培养、ELISA 试剂盒、技术服务、耗材、实验室仪器 / 设备、体外诊断、论文服务

  • 经营模式:

    代理商

在线沟通

技术资料/正文

人Th亚群分化方案

187 人阅读发布时间:2025-09-18 09:21

人Th亚群分化方案

准备培养基
1640培养基、血清(胎牛)、双抗、L-谷氨酰胺、B-巯基乙醇

培养基配置
RPM-1640+10%胎牛血清+1mML-谷氨酰胺+55μM B-基乙醇+双抗

准备细胞
分选出Naive CD4*T cells(CD4*CD25-CD44!0CD62Lhigh)

细胞刺激培养
1.CD3包板:包板浓度2μg/ml(96孔板加50ul,48孔板加200ul)加入上述体积后4度过夜包被,包被后弃去孔内液体,PBS洗板2次。
2.分选的Naive CD4*Tcells加入包被孔内。
 a)96孔板加入1*105细胞(200y培养体系)
 b)48孔板加入2*105细胞(500μl培养体系)
3.配置分化培养基(4μl/mlanti-human CD28+10 ng/ml HumanIL2)
根据需要分化的方向额外添加以下成分:
a)TH1,IL-12 (50 ng/ml) plus anti-human lL-4 (10 ug/ml)
b)TH2,IL-4(50ng/ml) plus anti-human lFN-y(10 ug/ml)
c)TH17,1L-6 (50 ng/ml),iL-1β (10 ng/ml),lL-23 (10 ng/ml), TGF-β (10 ng/ml)plus-an-ti-human lFN-y(10 ug/ml) and anti-human lL-4 (10 ug/ml)
e) TH9,IL-4 (50 ng/ml),TGF-β (10 ng/ml), plus anti-human lFN-y(10ug/ml)
f)TH22,1L-6 (50 ng/ml),L-23(50 ng/ml), plus anti-human lFN-y (10 ug/ml) andanti-human lL-4 (10 ug/ml)
g)Tfh,1L-6(50 ng/ml),IL-21 (10 ng/ml),cxCL13 (10 ng/ml).

4.细胞培养分化3-5天,培养过程中若培养液上清变黄,更换培养基,一般建议半量换液,根据培养经验,一般是隔天换液。
5.培养分化后鉴定(胞内染色):分化后的细胞加入20ng/mPMA,lug/mllonomycin刺激30min后,加入10ug/mIBFA阻断,继续培养3.5h后收集细胞进行流式检测。
6.细胞鉴定:购买相应的流式抗体及辅助试剂进行胞内染色鉴定。
 

生产商 产品编号 产品名称 产品规格
PeproTech 200-01b Recombinant Human lL-1B 2 ug/10 ug/50 ug/100 μg/250 μg/500 ug/1000 ug
PeproTech 200-02 Recombinant HumanIL-2 10 ug/50 μg/100 μg/250 μg/500 μg/1000 μg
PeproTech 200-04 Recombinant Human lL-4 5 ug/20 ug/50 ug/100 μg/250 μg/500 μg/1000 μg
PeproTech 200-06 Recombinant Human lL-6 5 ug/20 ug/50 ug/100 μg/250 μg/500 μg/1000 μg
PeproTech 200-12 Recombinant Human lL-12 2 ug/10 ug/50 ug/100 μg/250 μg/500 ug/1000 ug
PeproTech 200-21 Recombinant HumanlL-21 2 ug/10 ug/50 ug/100 μg/250 μg/500 ug/1000 ug
PeproTech 200-23 Recombinant Human lL-23 2 ug/10 ug/50 ug/100 μg/250 μg/500 ug/1000 ug
PeproTech 300-47-5 Human BCA-1(CXCL13) 5 ug/20 ug/50 ug/100 μg/250 μg/500 μg/1000 μg
PeproTech 100-21 Human TGF-beta1-Mammalian 2 ug/10 ug/50 ug/100 μg/250 μg/500 ug/1000 ug
BioGems 05121-25 Anti-Human CD3 SAFIER Purifed 100 μg/500 μg
BioGems 10311-25 Anti-Human CD28 SAFIER Purifed 100 μg/500 μg
BioGems 80821-25 Anti-Human IFN-y SAFIRE Purified 100 μg/500 μg
BioGems 81121-25 Anti-Human IL-4 SAFIRE Purified 100 μg/500 μg


细胞鉴定所需试剂:

生厂商 产品编号 产品名称 规格
BioGems 05121-40 Anti-Human CD3 BG Violet 450 25 tests/100 tests
BioGems 10111-50 Anti-Human CD8a FITC 25 tests/100 tests
BioGems 80811-77 Anti-Human lFN gamma PE-Cy7 25 tests/100 tests
BioGems 81121-80 Anti-Human IL-4 APC 25 tests/100 tests
BioGems 73821-60 Anti-Human IL-17A PE 25 tests/100 tests
BioGems 44212-77-100 Mouse lgG1 lsotype Control PE-Cy7 100 μg
BioGems 42813-80-100 Rat lgG1 lsotype Control APC 100 μg
BioGems 44212-60-100 Mouse lgG1 lsotype Control PE 100 μg
BioGems 2031560-5mg Brefeldin A 5 mg
BioGems 5608212-1mg lonomycin (calcium salt) 1 mg
BioGems 1652981-1mg Phorbol12-myristate 13-acetate 1 mg
BioGems 92110-00-150 Permeabilization Buffer(10X) 150 ml
BioGems 92160-00-160 Transcription Factor Fixation/Permeabilization 160ml
BioGems 92550-00-50 Transcription Factor Fixation/Permeabilizatio Concentrate Diluent 50 ml


参考文献:
1.Carbo A, Hontecillas R, Andrew T, et al. Computational modeling of heterogeneity andfunction of CD4*Tcells. Front Cell Dev Biol. 2014;2:31.
2.O'Conor W, Jr., Zenewicz LA, Flavell RA. The dual nature of T(H)17 cells: shifting thefocus to function. Nat lmmunol. 2010;11:471-476.
3.Schmitt N, Ueno H. Regulation of human helper T cell subset differentiation by cytokines. Curr Opin lmmunol. 2015;34:130-136.
4.Crotty S. T follicular helper cell differentiation, function, and roles in disease. lmmunity.2014:41:529-542.
5.Gegnat J, Paroni M, Maglie S, et al. Plasticity of human CD4 Tcell subsets. Front lmmu-nol. 2014:5:630.

电话:0512-67895080
QQ:3658813622
邮箱:info@ecellbio.com
网址: www.ecellbio.com
地址:江苏省苏州市工业园区裕新路 168 号脉山龙大厦 2 幢


 

资料格式:

F03人Th亚群分化方案.pdf

查看详细文档

上一篇

人CIK细胞培养方案

下一篇

人外周血来源T细胞扩增方案

我的询价